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We studied the expression of transfected chicken and hamster vimentin genes in murine erythroleukemia
(MEL) cells. MEL cells normally repress the levels of endogenous mouse vimentin mRNA during inducer-
mediated differentiation, resulting in a subsequent loss of vimentin filaments. Expression of vimentin in
differentiating MEL cells reflects the disappearance of vimentin filaments during mammalian erythropoiesis in
vivo. In contrast, chicken erythroid cells express high levels of vimentin mRNA and vimentin filaments during
terminal differentiation. We demonstrate here that chicken vimentin mRNA levels increase significantly in
differentiating transfected MEL cells, whereas similarly transfected hamster vimentin genes are negatively
regulated. In conjunction with in vitro nuclear run-on transcription experiments, these results suggest that the
difference in vimentin expression in avian and mammalian erythropoiesis is due to a divergence of cis-linked
vimentin sequences that are responsible for transcriptional and posttranscriptional regulation of vimentin gene
expression. Transfected chicken vimentin genes produce functional vimentin protein and stable vimentin
filaments during MEL cell differentiation, further demonstrating that the accumulation of vimentin filaments
is determined by the abundance of newly synthesized vimentin.
Intermediate filaments represent a family of cytoskeletal
structures whose members are expressed in developmentally
regulated and tissue-specific patterns in vertebrate cells.
Keratins are expressed in epithelial cells and cells of epithe-
lial origin, desmin in smooth and striated muscle, glial
fibrillary acidic protein in glial cells, neurofilaments in
neuronal cells, and vimentin in a wide variety of both
immature and differentiated cell types (reviewed in refer-
ences 47 and 84). The specificity of intermediate-filament
protein expression in developing cell lineages suggests that
each intermediate-filament protein type plays an important
morphogenetic role in cellular differentiation. An interesting
facet of the study of intermediate-filament proteins indeed
pertains to their patterns of developmental and tissue-
specific regulation. Vimentin expression is both positively
and negatively regulated during the differentiation of a
variety of cell types. For example, in chicken spinal cord,
vimentin is replaced by neurofilament protein during the
terminal differentiation of neurons (86). In muscle, astro-
cytes, and certain retinal neurons, vimentin is coexpressed
with the cell type-specific intermediate-filament protein
(desmin, glial fibrillary acidic protein, and neurofilament
protein, respectively) in the fully differentiated state (24, 33,
80, 86, 95). Fibroblasts, lens fibers, and avian erythrocytes
express vimentin as the major intermediate-filament protein
subunit of the mature cell (8, 29, 36, 77).
The generality and diversity of vimentin expression sug-
gest that its regulation is necessarily complex. This complex-
ity is particularly evident from a comparison of avian and
mammalian erythropoiesis. The mature avian erythrocyte is
a nucleated biconvex ellipsoidally shaped cell. Ultrastruc-
tural analyses of avian erythrocytes have revealed a network
of intermediate filaments that spans the cytoplasm and
appears to anchor the centrally located nucleus (34, 89, 92).
The major subunit protein of these filaments is vimentin (36).
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In contrast, the anucleate, biconcave disk-shaped mamma-
lian erythrocyte contains no intermediate filaments. Studies
of human hematopoiesis in vivo have demonstrated that
vimentin is expressed early in erythroid differentiation but is
lost in the erythroblastic stages (22).
In chicken erythroid cells, vimentin filaments are assem-
bled rapidly and stably from a soluble pool of newly synthe-
sized vimentin (5, 62). The efficiency and rapidity of
vimentin assembly in vivo suggest that the extent of
vimentin filament formation is determined primarily by the
amount of vimentin synthesized. We have shown that the
expression of vimentin protein during erythropoiesis is de-
termined primarily by mRNA abundance (10, 69). In chicken
embryonic erythropoiesis, vimentin mRNA is found at low
levels in immature, mitotic primitive cells and accumulates
to increasingly higher levels during terminal differentiation
of the definitive erythroid lineage, apparently underlying
similar changes at the protein level (10). During differentia-
tion of murine erythroleukemia (MEL) cells in vitro,
vimentin mRNA levels rapidly and extensively decline (-25-
fold reduction), rendering a concomitant decrease in
vimentin synthesis and a subsequent loss of vimentin fila-
ments (69). The striking difference in the changes of vimentin
mRNA abundances (and, ultimately, vimentin filaments)
during mammalian and avian erythropoiesis presents an
opportunity to study not only the factors responsible for the
dynamic positive and negative regulation of the vimentin
gene but also the basis for the evolutionary divergence of the
two erythropoietic programs with regard to vimentin expres-
sion.
In the present study, we addressed these issues by exam-
ining the behavior of transfected chicken and hamster
vimentin genes in differentiating MEL cells. The utility of
studying both resident and transfected genes during in vitro
differentiation of MEL cells is well established (reviewed in
references 13 and 55). We demonstrate that, in MEL cell
lines harboring and expressing chicken vimentin genes,
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chicken vimentin mRNA levels either increased 2- to 10-fold
or remained constant during dimethyl sulfoxide (DMSO)-
mediated differentiation, whereas resident mouse vimentin
mRNA levels declined extensively (10- to 20-fold). Expres-
sion ofmRNA from transfected hamster vimentin genes was
reduced significantly in differentiating MEL cells. These
results suggest that the divergence in vimentin expression in
mammalian and avian erythropoiesis is due to a divergence
of elements linked to vimentin sequences in cis. Our results
further suggest the existence of general erythroid cell-
specific trans-acting factors which have been functionally
conserved from birds to mammals and interact with chicken
vimentin regulatory sequences in murine erythroid cells in a
manner appropriate for chicken vimentin sequences in a
chicken erythroid cell environment.
MATERIALS AND METHODS
Construction of plasmid DNAs. Manipulations of DNA
were carried out by standard protocols (54). For the trans-
fection of adenine phosphoribosyltransferase (APRT)-de-
ficient (aprt-) cells with chicken vimentin sequences, a
plasmid containing the entire chicken vimentin gene, with
2.5-kilobase (kb) 5'- and 3'-flanking sequences, plus the
hamster APRT gene was constructed in pUC18. A 3.7-kb
HincII-BamHI fragment from a X genomic chicken vimentin
recombinant, XV8 (10), containing the 5' end of the gene plus
2.5-kb upstream sequences, was inserted into the polylinker
region of pUC18 cleaved with HincIl and BamHI. The
resulting plasmid was then linearized with HincII, and this
site was replaced by the ligation of XhoI linkers, rendering
plasmid pS'VIMXB-1. The remainder of vimentin gene se-
quences, plus 3.8-kb 3'-flanking sequences contained in an
11.3-kb BamHI fragment of XV8, were ligated to the BamHI
site of p5'VIMXB-1, yielding plasmid pVIMXBB. A 1.3-kb
fragment at the 3' end of the chicken genomic insert was
removed by digestion with Asp718 (an isoschizomer of
KpnI), and hamster APRT gene sequences were inserted on
a 4.0-kb BglII-Asp7l8 DNA fragment (53) by successive
ligation of Asp718-generated cohesive ends, blunting of the
remaining nonhomologous Asp718 and BglII ends with DNA
polymerase I large fragment, and blunt-end ligation, yielding
the final 20-kb plasmid, pAV21 (see Fig. la).
The hamster vimentin gene was isolated on a 14.5-kb
BamHI fragment (73) from a X EMBL3 genomic library
prepared from size-fractionated, BamHI-digested BHK-21
DNA (data not shown). pAV21 was digested with HindIII
and BamHI, BamHI linkers were ligated to the polymerase-
blunted ends (corresponding to the polylinker HindIII site
and hamster APRT gene 5'-flanking BamHI site) of the
6.7-kb fragment containing the hamster APRT gene plus
pUC18, and the DNA was circularized to yield pUC-APRT.
The 14.5-kb BamHI fragment carrying hamster vimentin
sequences was then ligated to the BamHI ends of pUC-
APRT, yielding pAHV3 (see Fig. lb).
Cell culture and transfections. An adherent aprt- MEL cell
line, Faprt-585-S (14, 20), was maintained at 37°C and 5%
CO2 in Dulbecco modified eagle medium supplemented with
15% heat-inactivated fetal bovine serum and penicillin-
streptomycin plus 50 jig of 2,6-diaminopurine per ml (DAP
medium) to continually select for the aprt- phenotype. Cells
were cultured in the absence of DAP (neutral medium) for
several days before DNA transfection. Two methods were
used to introduce DNA into MEL cells. Poly-L-ornithine-
mediated transfections were carried out as described previ-
ously (6). At 16 to 20 h before DNA transfection, cells were
plated at a density of 1 x 106 to 2.5 x 106 cells per 100-mm
(diameter) tissue culture dish. At the time of transfection,
plates were washed once with Earle balanced salt solution
and once with Tris-buffered saline (25 mm Tris chloride, 137
mM NaCl, 5 mM KCI, 1.4 mM Na2HPO4, 10 mM CaC12, 5
mM MgC92, pH 7.5). One milliliter of Tris-buffered saline
solution containing either 8 pug of Asp718-cleaved pAV21
DNA plus 28 jig of poly-L-ornithine or 4 ,ug of DNA plus 10
,ug of poly-L-ornithine was added to each drained plate, and
cells were incubated with the DNA-poly-L-ornithine solu-
tions at 37°C for 3 h with occasional rocking of the plates.
The DNA-poly-L-ornithine solutions were removed, and the
plates were washed twice with Tris-buffered saline. Neutral
medium was then added, and the cells were allowed to
recover and express APRT activity for 18 h. aprt+
transformants were then selected by incubation with me-
dium containing 4 ,ug of azaserine per ml and 15 ,ug of
adenine per ml (AZA-AD medium). Individual MEL cell
colonies were isolated in cloning cylinders and expanded for
further analysis. The efficiency of DNA transfer into
Faprt-585-S cells by this method was difficult to assess,
since the concentrations of DNA and poly-L-ornithine used
here were toxic to the cells and an undetermined number of
cells was lost (250%) when plates were washed after incu-
bation with DNA-poly-L-omithine. Nevertheless, we ob-
served aprt+ colonies in approximately one of every two to
three plates, yielding a transfection efficiency of one aprt'
transformant per initial -4 x 106 to 1 x 107 cells. We also
introduced DNA into Faprt-585-S cells by calcium phos-
phate precipitation as previously described (91). Briefly,
cells were plated in 10 ml of neutral medium on 100-mm
tissue culture dishes at a density of 6 x 105 cells per plate at
18 h before addition of the calcium phosphate-DNA precip-
itate. One milliliter of precipitate containing 30 ,ug ofAsp718-
cleaved pAV21 or pAHV3 DNA was added to each plate.
Medium containing the calcium phosphate-DNA precipitate
was removed after 20 to 22 h of incubation at 37°C and
replaced with neutral medium for 24 h. aprt+ transformants
were then selected as described above. We observed aprt+
transformants at an approximate frequency of 1 per 2 x 106
to 5 x 106 cells. Cells transfected with pAV21 by the
poly-L-ornithine protocol described above were designated
MELCVO (chicken vimentin-ornithine), whereas calcium phos-
phate-generated transformants were designated MELCV.
The hamster vimentin construct was introduced into MEL
cells only by calcium phosphate precipitation, and the re-
sulting cells were designated MELAHV.
Analysis of aprt+ MEL transformants and isolation of RNA.
aprt+ clones were grown and tested for the presence of
exogenous vimentin sequences by genomic DNA blotting
with appropriate vimentin-specific probes (data not shown).
Cells containing either the entire chicken genomic portion of
pAV21 or the entire 14.5-kb BamHI hamster genomic frag-
ment of pAHV3 were studied further. Cells were adapted to
growth in bacterial dishes to facilitate differentiation (14) and
cultured in AZA-AD medium (undifferentiated cells) or
induced to differentiate in AZA-AD medium plus 1.8%
DMSO for 4 to 5 days (30). Faprt-585-S cells were induced
to differentiate for 4 days in DAP medium plus 1.8% DMSO.
Cells were harvested, and total cellular RNA was prepared
by the method of Chirgwin et al. (18) as modified (69). Spinal
cord RNA from 1-week-old chickens was isolated as previ-
ously described (10), and cytoplasmic RNA was prepared
from 15-day-old chicken embryo erythroid cells (63).
Poly(A)+ RNA was purified by oligo(dT)-cellulose chroma-
tography (2).
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Determination of RNA levels by quantitative RNase protec-
tion mapping. Steady-state mRNA levels of chicken and
murine vimentin, hamster APRT, mouse ,B-globin, and
mouse y-actin were assayed by protection of in vitro-
synthesized complementary 32P-labeled RNAs from RNase
digestion by cellular RNAs (60, 98). Several plasmids were
constructed in pT7SP6 (3) for the synthesis of 32P-RNA
probes (see below). For the detection of chicken vimentin 5'
sequences, the 3.7-kb HincII-BamHI fragment of XV8, con-
taining exons 1 and 2, was inserted into the respective
polylinker sites in pT7SP6. For probe synthesis, the tem-
plate was cleaved with HindIll, and a 1.9-kb 32P-labeled
complementary RNA was generated with T7 phage polymer-
ase (see Fig. 2b). A 1-kb chicken vimentin 3'-specific probe
was synthesized with T7 phage polymerase from a template
consisting of 3' untranslated sequences 143 nucleotides (nt)
downstream of the translation termination codon (95a)
through 0.6 kb of 3'-flanking sequences (see Fig. 4b). For
P-globin RNA analysis, the 5' 1.9-kb EcoRI-BamHI frag-
ment from the mouse P-major-globin genomic insert of
pMB9-PG2 (45) was subcloned (p,5'). A BstNI-cleaved pp35'
template was transcribed with SP6 phage polymerase, yield-
ing 32P-labeled RNA complementary to intervening se-
quence (IVS) 1 and exon 2 (see Fig. 3b). A hamster APRT-
specific probe was synthesized with SP6 phage polymerase
from a BamHI-cleaved template containing a 0.9-kb hamster
APRT gene fragment (p5'APRT, see Fig. 3d). This probe is
protected by exons 1 and 2 of APRT and also contains IVS
1 and a portion of IVS 2 sequences (64, 65). Mouse y-actin
RNA was detected with a probe synthesized from a human
-y-actin template cloned in pSP64 (26).
32P-labeled complementary RNA probes were synthesized
with SP6 or T7 phage polymerases, using the above-
mentioned templates, essentially under conditions described
by Zinn et al. (98). [a-32P]CTP (3,000 Ci/mmol) was diluted
with unlabeled CTP and included in the transcription reac-
tions at the following final concentrations and specific activ-
ities: 50 ,uM at 200 Ci/mmol for 5' vimentin, 50 ,uM at 50
Ci/mmol for P-globin, and 100 puM at 100 Ci/mmol for APRT,
y-actin, and 3' vimentin.
Typically, 1 x 105 to 2 x 105 cpm of [32P]RNA was hy-
bridized to 10 pug ofMEL cell total RNA at 45°C for 14 to 17
h in 30 ,u1 of 80% formamide-40 mM PIPES (piperazine-
N,N'-bis(2-ethanesulfonic acid)-400 mM NaCl-1 mM
EDTA, pH 6.4. The hybridization reactions were then
diluted with 300 p.l of 20 mM Tris chloride (pH 7.5)-300 mM
NaCl-5 mM EDTA-50 jig of RNase A per ml-900 U of
RNase T1 per ml and incubated at 30°C for 1 h. Ten
microliters of 20% sodium dodecyl sulfate (SDS) and 100 p.g
of proteinase K were added, and samples were digested at
37°C for 30 to 60 min. Following phenol extraction, 10 p.g of
carrier beef liver tRNA was added, and RNA was precip-
itated with ethanol. Protected [32P]RNA fragments were
resolved on 0.25-mm-thick, 5% polyacrylamide-8 M urea
denaturing gels (56) and exposed to Kodak XAR-5 film with
intensifying screens.
For quantitation, 32P radioactivity in gel slices was as-
sayed by Cerenkov radiation, as detected in the 3H channel
of a Beckman model 1801 liquid scintillation counter; each
sample was counted for 20 min. Liquid scintillation counting
of gel slices immersed in fluor gave similar results. The
following gel slices were excised for quantitation: the 632-nt
exon 1 fragment for chicken vimentin; the 209- and 81-nt
fragments for f-major-globin and P-minor-globin, respec-
tively; the 111-nt exon 2 fragment for hamster APRT; and
the 80-nt fragment for mouse y-actin. Radioactivity in gel
slices was directly proportional to the amount of RNA
hybridized, as determined by serial dilution of cellular RNAs
(data not shown). In cases in which radioactivity was too low
to be determined accurately (less than 2 a above background
+ 2 cr), autoradiograms using preflashed film were scanned
with a densitometer, and peak areas were integrated. The
data of Table 1 were derived from the gels shown in Fig. 2
and 3. Results qualitatively similar to the ones shown here
were obtained in separate multiple determinations (data not
shown).
Metabolic labeling with [35S]methionine and immunofluo-
rescence microscopy. MEL cells cultured in the absence or
presence of 1.8% DMSO for 4 days were labeled with
[35S]methionine for 1 h as described previously (69). Equiv-
alent amounts of protein-incorporated [35S] radioactivity in
Triton X-100-insoluble residues (5, 62) from each sample
were loaded on two-dimensional isoelectric focusing-SDS-
polyacrylamide gels (70); gels were stained with Coomassie
blue to visualize total protein and then impregnated with
2,5-diphenyloxazole for fluorography (7). Immunofluores-
cence microscopy with an anti-chicken vimentin antiserum
(33) was performed exactly as described previously (69).
Detection of hamster vimentin mRNA by quantitative
primer extension analysis. An oligonucleotide with the se-
quence 5'-TGCGAACCGCGGGAGTGCTG-3' (synthesized
at the Caltech Microchemical Facility) was labeled with T4
polynucleotide kinase in the presence of [y-32P]ATP and
used for primer extension analysis, essentially as described
by Jones et al. (39). This oligonucleotide is complementary
to hamster vimentin mRNA in the 5' noncoding region,
between positions 37 and 56 relative to the RNA initiation
site (73). 32P-labeled oligonucleotide primer (0.1 pmol) was
hybridized to total cellular RNA for 2 h at 55°C in 10 p.l of 10
mM Tris chloride (pH 8)-250 mM NaCl-2 mM EDTA.
Samples were diluted with 25 p.l of 50 mM Tris chloride (pH
8.7)-10 mM MgCl2-5 mM dithiothreitol-350 p.M dATP,
TTP, dCTP, and dGTP-10 pug of actinomycin D per ml-600
U of RNasin per ml-330 U of AMV reverse transcriptase
(FPLC purified; Pharmacia) per ml and incubated for 1 h at
42°C. Following phenol extraction and ethanol precipitation,
extension products were separated on 0.25-mm-thick 8%
polyacrylamide-8 M urea gels and visualized by exposure to
Kodak XAR-5 film in the presence of an intensifying screen.
The 53- to 57-nt extension products, corresponding to cor-
rectly initiated hamster vimentin mRNA, were quantitated
by Cerenkov radiation determination of excised gel slices.
Serial dilution of BHK-21 RNA (a source of high levels of
hamster vimentin RNA) over a 20-fold range yielded a
commensurate decrease in radioactive extension products
(data not shown). Tripling the amount of 32P-labeled oligo-
nucleotide primer in hybridizations had no effect on the
amount of extension product synthesized (data not shown).
In vitro nuclear run-on transcriptions. Transcription in
isolated nuclei was performed by an amalgam of several
published procedures (11, 37, 52, 57). MEL cells were
cultured for up to 4 days in the presence or absence of 1.8%
DMSO. Cells were washed several times in phosphate-
buffered saline and lysed in ice-cold reticulocyte standard
buffer (10 mM Tris chloride, 10 mM NaCl, 5 mM MgCl2, pH
7.4) plus 0.5% Nonidet P 40, 1 mM dithiothreitol, and 50 to
100 U of RNasin per ml. All subsequent steps were carried
out at 0°C, unless otherwise noted. Nuclei were pelleted by
centrifugation at 1,000 x g for 4 min, and postnuclear
supernatants were saved for preparation of cytoplasmic
RNA by phenol-chloroform extraction. Nuclear pellets were
rinsed gently in reticulocyte standard buffer alone,
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repelleted, and suspended in nuclear freezing buffer (50 mM
Tris chloride [pH 8.0], 5 mM MgCl2, 0.1 mM EDTA, 40%
[wt/vol] glycerol) at an approximate density of 107 nuclei per
100 ,ul. Nuclei either were frozen and stored at -70°C and
thawed before use (experiment 1), or used immediately
(experiment 2 and MEL-Fl transcriptions).
Each transcription reaction was carried out with -107
nuclei. Nuclei were preincubated at 0°C for 5 to 10 min in
nuclear freezing buffer, pelleted for 8 to 10 s in a variable-
speed Eppendorf microcentrifuge (setting 5), and suspended
in 50 ,ul of nuclear freezing buffer. Fifty microliters of 2x
run-on buffer (10 mM Tris chloride [pH 8], 300 mM KCl, 5
mM MgCl2, 1 mM dithiothreitol, 10 mM creatine phosphate,
0.1 mg of creatine phosphokinase per ml, 1 mM each ATP,
CTP, and GTP) containing 320 ,uCi of [a-32P]UTP (-3,000
Ci/mmol) was added to each sample, and transcription was
allowed to proceed for 15 min at 30°C. We determined that
incorporation of [at-32PJUTP into RNA was linear for this
duration at 30°C in both uninduced and induced nuclei (data
not shown). Nuclei were iced, pelleted, suspended in 200 ,ul
of 20 mM Tris chloride (pH 7.5)-10 mM MgCl2-2 mM CaCl2
plus 40 ,ug of carrier beef liver tRNA, and high-molecular-
weight DNA was digested with 75 U of DNase I (FPLC
purified; Pharmacia) at 30°C for 15 min. Samples were
digested by addition of 10 p.l of 20% SDS and 100 ,ug of
proteinase K and incubation at 42°C for 45 to 60 min. RNA
was isolated by phenol-chloroform extraction and ethanol
precipitation and was separated from unincorporated [a-
32P]UTP by chromatography on 1-ml Sephadex G-50 (me-
dium) spin columns. Within a given experiment, equivalent
amounts of radioactivity (3.5 x 106 cpm in experiment 1, 7.0
x 106 cpm in experiment 2, and 1 x 107 cpm in MEL-Fl
transcriptions) were hybridized to nitrocellulose filters in 1
ml of solution.
Plasmid DNAs were linearized and immobilized on nitro-
cellulose as described by Kafatos et al. (40), by using a
Schleicher & Schuell dot blot apparatus. Ten micrograms of
each plasmid was applied to each dot. The plasmids used
were pVIMXBB for detection of chicken vimentin gene
transcription; pSThvim, a pT7SP6 recombinant containing
the 14.5-kb BamHI hamster vimentin genomic fragment, for
mouse vimentin; pP5' for ,-globin; pSP64-y-actin for mouse
-y-actin, pUC-APRT for hamster aprt; and pT7SP6 as a
negative control. Filters were prehybridized at 65°C for 2 h
in 20 mM Tris chloride (pH 7.5)-10 mM EDTA-0.3 M
NaCl-0.2% SDS (2x TESS), plus 0.25 mg of beef liver tRNA
per ml and lx Denhardt solution. 32P-labeled RNA in TE
was heated to 65°C for 2 to 3 min, iced, and added to 1 ml of
2x TESS-0.1 mg of beef liver tRNA per ml-lx Denhardt
solution preheated to 65°C and hybridized in microcentrifuge
tubes at 65°C for 45 h (experiment 1), 61 h (experiment 2), or
66 h (MEL-Fl transcriptions). Filters were washed three
times with 2x SSC (lx SSC is 0.15 M NaCl plus 0.015 M
sodium citrate, pH 7.0) at 65°C for 30 min each and once with
2x SSC at room temperature, digested with 5 p.g of RNase A
per ml and 25 U of RNase T1 per ml in 2x SSC at 37°C for
30 min, washed finally in three to four changes of 2x
SSC-0.2% SDS at 65°C for 30 min each, air dried, and
exposed to preflashed Kodak XAR-5 film with intensifying
screens. Radioactivity in each dot was quantitated by
Cerenkov radiation as described above. For each individual
filter, the radioactivity in the pT7SP6 dot (18 to 20 cpm, less
than 1 or 2 cpm over the machine background) was sub-
tracted from the gross radioactivity of each of the other dots.
Dilution of input radioactivity in the hybridization yielded
comparable decreases in hybridized RNA. Inclusion of 2 p.g
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FIG. 1. Plasmid DNA constructs used for transfection of MEL
cells. (a) Structure of pAV21, a chicken vimentin-hamster APRT
plasmid. (b) Structure of pAHV3, a hamster vimentin-hamster
APRT plasmid. Solid bars indicate gene coding regions. Open bars
indicate vimentin flanking sequences, whereas hatched bars show
APRT flanking sequences.
of a-amanitin per ml in nuclear preincubations and transcrip-
tions abolished all detectable radioactivity bound to the
above-described plasmid dots, indicating that the transcrip-
tion as assayed by our plasmids was due to RNA polymerase
II activity (41, 51).
RESULTS
Transfection of MEL cells with the chicken vimentin gene.
We constructed a plasmid, designated pAV21, specifically
for the introduction of chicken vimentin gene sequences into
APRT-deficient cells (Fig. la). pAV21 contains the entire
7.7-kb chicken vimentin gene coding sequence (10, 95a),
with 2.5-kb 5'- and 3'-flanking sequences, plus a 4.0-kb
hamster genomic DNA fragment containing the hamster
APRT gene (53). pAV21 was linearized with Asp718 and
introduced into an aprt- MEL cell line, Faprt-585-S (14,
20), by calcium phosphate precipitation (91) or poly-L-
ornithine-mediated transfection (6). Of 52 independent aprt+
MEL cell clones isolated and expanded for analysis, 28
possessed intact chicken vimentin gene sequences, as judged
by genomic DNA blotting (data not shown). Using either
method of transfection, the copy numbers of chicken
vimentin genes ranged from 1 copy to -10 to 20 copies per
cell (data not shown; see Table 1).
Analysis of chicken vimentin mRNA expression in differen-
tiating MEL cells. MEL cell lines harboring intact chicken
vimentin sequences were either grown in the absence of
chemical inducer (undifferentiated cells) or induced to dif-
ferentiate by culturing in the presence of 1.8% DMSO for 4
to 5 days (30), and total cellular RNA was isolated. Chicken
vimentin RNA was detected by quantitative RNase protec-
tion of a homogeneously labeled 1.9-kb [32P]RNA probe
specific for exons 1 and 2 (Fig. 2b). Figure 2a, lane 2,
demonstrates protection of portions of the RNA probe
corresponding to the 632-nt exon 1 and 61-nt exon 2 se-
quences of vimentin RNA from chicken embryo fibroblasts.
This probe apparently also hybridizes to mouse vimentin
RNA sequences, rendering a 70-nt protected fragment (Fig.
2a, lane 3; compare with tRNA control). This 70-nt fragment
was not detected in RNAs from differentiated MEL cells
(Fig. 2a, lane 4) and was absent from RNA preparations
derived from other murine cell lines devoid of vimentin
mRNA, such as the plasmacytomas MPC-11 and MOPC-31C
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(58; data not shown). Ten MEL cl
rectly initiated chicken vimentin RI
(Fig. 2a, lanes 5 to 24). Seven
MELCV-5, MELCV-11, MEL(
MELCVO-12, and MELCVO-16, in(
chicken vimentin RNA 2- to 10-fol
(Fig. 2a; see Table 1). With the exc
the rest of the chicken vimentin-exl
tained relatively constant levels of
during DMSO-mediated differentiation. MELCVO-26 cells
expressed chicken vimentin RNA only at very low levels,
and upon differentiation, these levels decreased by approx-
imately two- to fivefold. The variations in levels of expres-
sion and induction are typical for transfected genes in this
and other systems (e.g., see reference 13). As an internal
control, we observed that mouse vimentin RNA levels
decreased by >10-fold during differentiation of all MEL cell
lines, as judged by the 70-nt fragment protected by mouse
vimentin RNA sequences (Fig. 2a).
Among the cell lines which induced chicken vimentin
RNA during DMSO-mediated differentiation, MELCV-5,
MELCV-26, and MELCVO-12 expressed the chicken RNA
after differentiation at levels comparable to or greater than
the levels of endogenous mouse vimentin RNA found in
undifferentiated cells (compare the 70-nt protected fragment
of mouse vimentin with the 61-nt protected fragment of
chicken vimentin in lanes 5 and 6, 11 and 12, and 15 and 16).
Experiments similar to the one shown in Fig. 2a were
performed several times, with results qualitatively similar to
those shown here (data not shown).
Anialysis of P-globin RNA levels in transfected MEL cells.
To assess the extent of differentiation of each of the cell lines
- , ', expressing chicken vimentin RNA, we analyzed the levels of
--globin RNA during differentiation of a selected subset of
cell lines. A. 345-nt 32P-labeled RNA, complementary to
mouse P-major-globin sequences from the 5' end of the first
intervening sequence (excluding the first 9 nt) to the 3' end of
exon 2 (excluding the last 13 nt) (45), was synthesized and
used as a probe in RNase protection experiments (Fig. 3b).
A 209-nt protected fragment corresponding to exon 2 of the
-major-globin mRNA was induced 50-fold in the parent
MEL' cell line (Fig. 3a, lanes 2 and 3; Table 1). Our
... *. ,B-major-globin probe also detected the presence of ,-minor-
globin transcripts, as evidenced by the protection of an 81-nt
fragment, corresponding to homology with sequences be-
tween nucleotide positions 262 to 342 of P-major-globin (45).
RNA levels in undifferen- The pattern shown in lanes 2 and 3 indicates that the parent
EL cells. (a) A 32P-labeled MEL cell line used in this study, Faprt-585-S, exhibits a
and 2 of chicken vimentin high ratio of P-minor-globin to P-major-globin RNA and
lar RNAs and subjected to expresses a significant amount of ,-minor-globin RNA in the
Is and Methods. Protected undifferentiated state; the induction of P-minor-globin RNA
oolyacrylamide gels. Lanes: in these cells was three- to fourfold. As a comparison, the
,rkers; tRNA,protection of induction pattern of ,-globin RNA from another MEL cellization with 10 pLg of tRNA;
nbryo fibroblast total RNA line, Mel-Fl, is shown in Fig. 3a, lanes 18 and 19. This MEL
von 1 and 61-nt exon 2 were cell line produces mainly 3-major-globin RNA upon differ-
Lg of MEL cell RNAs from entiation and comparatively little P-rrinor-globin RNA in
-nce (+) of 1.8% DMSO for either the undifferentiated or differentiated state. Variations
70-nt fragment by mouse in 3-major-globin and ,B-minor-globin ratios in different MEL
Les 1 to 18 was exposed for cell lines have been described previously (1). Figure 3a,
f 60- to 70-nt fragments lanes 4 to 17, and Table 1 show that MELCV-5, MELCV-11,
e 632-nt exon 1 fragment), MELCV-26, MELCV-29, MELCVO-2, MELCVO-12, and
osed for 4.5 days. Lanes MELCVO-16 all induced P-major-globin RNA by 10- to
the lower panel, the upper 120-fold (mean, 43-fold) and ,-minor-globin RNA by 2.5- to
7-fold (mean, 4-fold). Hence, the increases in chicken
vimentin RNA in differentiating MEL cells occurred in cells
undergoing extensive differentiation, as judged by 3-globin
ell lines expressed cor- RNA induction.
NA at detectable levels Analysis of hamster APRT and mouse y-actin RNA levels in
cell lines, MELCV-4, transfected MEL cells. The specificity of induction of chicken
CV-26, MELCVO-2, vimentin RNA levels in differentiating MEL cells was estab-
duced the expression of lished by assaying levels of hamster APRT RNA. If the
Id during differentiation transfected vimentin and APRT genes are independently
'eption of MELCVO-26, expressed in our cell lines, then we expect to find little or no
pressing cell lines main- correlation in the respective steady-state mRNA levels dur-
chicken vimentin RNA ing differentiation. We also measured endogenous y-actin
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FIG. 3. Analysis of 1-globin, hamster APRT, and mouse y-actin RNA levels in MEL cells. (aj ,B-Globin RNA analysis. A 32P-labeled RNA
probe for mouse ,-major-globin (panel b) was used for RNase protection and electrophoretic analysis as described in Materials and Methods
and the legend of Fig. 2. The ,-major-globin probe was protected by both P-major-globin mRNA (209-nt fragment) and 1-minor-globin mRNA
(81-nt fragment). Lanes: M, 32P-labeled pBR322-HpaII markers; tRNA, tRNA (10 p.g) control; 2 to 19, protection from 10 ,ug ofRNA isolated
from uninduced (-) and induced (+) MEL cells. The RNAs used in this assay, as well as in the assay in panel c, were from the same
preparations used for the experiments shown in Fig. 2. (c) Hamster APRT and mouse -y-actin RNA analysis. A mixed 32P-labeled RNA probe
consisting of a complementary y-actin RNA (26) and a complementary hamster APRT RNA (panel d) was used as described above. Protection
of the APRT probe generated fragments of 111 nt (exon 2) and 95 nt (exon 1); protection of the y-actin probe yielded an 80-nt fragment. Lanes:
M, pBR322-HpaII markers; tRNA, protection of mixed probe after hybridization with 10 ,ug of tRNA; 2 and 3, protection of 10 jig of
MELCVO-16 (induced) RNA with the APRT probe only or actin probe only, respectively; 4 to 19, protection of the mixed probe with 10 ,ug
of MEL cell RNA from DMSO-induced (+) or uninduced (-) cells.
RNA levels, since actin RNA levels are expected to exhibit
little, if any, change during MEL cell differentiation (69).
MEL cell RNAs were hybridized to a mixture of twp
32P-labeled RNA probes. The hamster APRT-specific probe
is a 0.9-kb RNA complementary to the 95-nt exon 1 and the
111-nt exon 2- of the APRT gene transcript (Fig. 3d). The
y-actin-specific probe is a complementary RNA derived
from human y-actin 3' sequences and protects an 80-nt
fragment from mouse y-actin RNA (26). Figure 3c shows
RNase protection experiments that measured simulta-
neously the steady-state levels of APRT and mouse y-actin
RNAs. Quantitation of this gel is tabulated in Table 1. A
comparison of hamster APRT RNA levels with chicken
vimentin RNA levels reveals no direct correlation in either
the amounts of RNA accumulated (compare Fig. 2a and 3c)
or the ratios of RNAs in induced versus uninduced cells
(Table 1). Mouse y-actin RNA levels varied less than two-
fold during MEL cell differentiation (Table 1), and the
differences observed most likely reflect clonal variations of
MEL cell isolates or variable levels of expression during
particular DMSO inductions.
Utilization of chicken vimentin gene polyadenylation sig-
nals. An interesting feature of the chicken vimentin gene is
the occurrence and utilization of multiple polyadenylation
sites (95a, 96, 97). Four consensus polyadenylation signals
(5'-AATAAA-3' [41) reside 250, 298, 533, and 554 nt down-
stream from the translation termination codon (95a, 96);
however, only polyadenylation signals the second through
fourth are utilized in the chicken tissues examined (97),
producing -2.0- and -2.3-kb mRNAs (10, 96). The utiliza-
tion of chicken vimentin polyadenylation sites is tissue
specific; definitive erythroid cells accumulate predominantly
the 2.0-kb mRNA, whereas other tissues and cell types
accumulate more equivalent amounts of the 2.0- and 2.3-kb
mRNAs (10). A comparison of hamster and chicken
vimentin gene sequences at their 3' ends reveals that the
b
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TABLE 1. Quantitation of steady-state RNA levels in undifferentiated and differentiated MELCV and MELCVO cells
Steady-state RNA ratio (differentiated level/undifferentiated level) of:
Celline ~ Approximate no. ofCell line transfected genes/celia Chicken Hamster Mouse Mouse
vimentin APRTb P-major-globinb j3-minor-globinb Mouse y-actln
MELFaprt-585-S 0 c - 50 3.7 1.7
MELCV-S 10-20 4b 1.0 9.1 2.5 0.7
MELCV-l1 10-20 2d 1.2 39 3.7 1.0
MELCV-26 1 2.9b 1.9 35 2.9 0.9
MELCV-29 10-20 1.2" 1.2 35 3.8 1.2
MELCVO-2 2-4 .10d 1.6 42 3.4 1.0
MELCVO-12 1 gb 1.3 120 7.2 0.7
MELCVO-16 2-4 >-5-10d 3.2 40 3.8 0.5
MELCV-4 1 3d ND? ND ND ND
MELCVO-23 1 1d ND ND ND ND
MELCVO-26 1 -0.2-0.5d ND ND ND ND
a Estimated from genomic DNA blots (data not shown).
b Determined by Cerenkov radiation in excised gel slices.
c-, No specific signals in these samples.
d Determined by densitometry of autoradiograms.
e ND, Not determined.
mammalian vimentin gene retains only one functional signal,
corresponding to the second chicken polyadenylation site
(73); both hamster and mouse cells produce -2.1-kb
vimentin m.RNAs (23, 69). We therefore were interested in
whether the mechanism by which polyadenylation signal 2 is
preferentially utilized in definitive chicken erythoid cells has
been conserved in mammals. To address this question, we
analyzed chicken vimentin RNA from transfected MEL cells
by performing RNase protection experiments with, as a
probe, a 1-kb RNA complementary to chicken vimentin
3'-terminal sequences, from 143 nt downstream of the trans-
lation termination codon (95a) past the last polyadenylation
signal (Fig. 4b). Chicken vimentin RNAs with 3' termini
generated from polyadenylation signals 2, 3, and 4 protect
170-, 410-, and 430-nt fragments of the RNA probe (Fig. 4a,
lanes 3, 10, and 11). Preferential utilization of polyadenyla-
tion signal 2 in 15-day-old chicken embryo erythroid cells
(lanes 3 and 10) as compared with chicken spinal cord (lane
11) was demonstrated in this experiment, in agreement with
previous findings (10). Total RNA from MEL cells express-
ing transfected chicken vimentin genes contains chicken
vimentin RNAs with ratios of 3' termini similar to those
fouid in chicken nonerythroid cells. MELCV-26 and
MELCV-29 cells accumulated similar ratios of chicken
vimentin RNAs in both the undifferentiated and differenti-
atFd states [lanes 4 to 7; compare with chicken definitive
erythroid RNA (lanes 3 and 10) and chicken spinal cord
poly(A)+ RNA (lane 11)]. All MEL cell lines that express
detectable chicken vimentin RNA displayed 3'-terminal pat-
terns identical to those shown here for MELCV-26 and
MELCV-29 (data not shown). Mouse fibroblastic L cells
transfected with pAV21 also accumulated ratios of chicken
vimentin transcripts similar to those of transfected MEL
cells (data not shown). The RNAs that exhibit these 3'
termini in MEL cells are bona fide polyadenylated tran-
scripts, as they are greatly enriched in the poly(A)+ RNA
fraction [compare 10 ,ug of total RNA from induced
MELCV-26 cells (lane 8) with 1 ,ug of poly(A)+ RNA derived
from the same total RNA preparation (lane 9)]. From these
experiments, we conclude that MEL cells do not discrimi-
nate among the multiple chicken vimentin polyadenylation
sites in a manner specific to chicken definitive erythroid
cells.
Transfected chicken vimentin genes produce functional
mRNAs and vimentin filaments in differentiating MEL cells.
We examined one MEL cell line, MELCV-26, for the syn-
thesis and stabilization of vimentin protein. MELCV-26 cells
contain high levels of chicken vimentin RNA, which in-
crease approximately threefold after differentiation in the
presence of DMSO (Fig. 2a, lanes 11 and 12, and 4a, lanes 4
and 5). Cells were maintained in control medium or induced
to differentiate in medium containing 1.8% DMSO for 4
days, incubated with [35S]methionine for 1 h, and fraction-
ated with Triton X-100. Equivalent amounts of Triton X-100-
insoluble protein-incorporated radioactivity were analyzed
by two-dimensional gel electrophoresis; this material repre-
sents newly synthesized, newly assembled cytoskeletal pro-
tein (5, 62). Even though newly synthesized and assembled
mouse vimentin was greatly reduced after differentiation in
both the parent cell line (Fig. 5a and b) and MELCV-26 cells
(panels c and d), newly synthesized and assembled chicken
vimentin was not only present in undifferentiated cells (panel
c) but increased in abundance upon differentiation (panel d).
Liquid scintillation counting of excised gel spots revealed
that chicken vimentin radioactivity increased 5- to 6-fold at 4
days of differentiation in MELCV-26 cells, whereas mouse
vimentin radioactivity decreased -4- to 5-fold in these cells
and 7- to 10-fold in the parent MEL cell line (data not
shown). Cytoskeletal chicken vimentin accumulated to high
steady-state levels after DMSO induction of MELCV-26
cells, as judged by Coomassie blue staining of the gels
(panels e and f), whose autoradiograms are shown in panels
c and d.
To ascertain whether cytoskeletal chicken vimentin was
present in a filamentous configuration, we performed indi-
rect immunofluorescence microscopy on undifferentiated
and differentiated MEL cells, using a vimentin-specific anti-
serum (33). Figure 6b and d, show that vimentin filaments
were lost during differentiation of the parent MEL cell line,
in accordance with our previous observations using another
MEL cell line, MEL-Fl (69). When we examined MELCV-26
cells, however, we observed a striking array of intensely
fluorescent vitnentin filaments in both undifferentiated and
differentiated cells (Fig. 6f and h). In several experiments,
we found that all of the MELCV-26 cells were vimentin-
positive, both before and after DMSO induction, indicating
that the transfected vimentin gene was expressed in all cells
in the population. Since the composition of cytoskeletal
vimentin in differentiated MELCV-26 cells is predominantly,
if not exclusively, chicken vimentin, the array shown in Fig.
VOL. 7, 1987
3962 NGAI ET AL.
a
an O"
2 -, 45C! '?9.1j-i
b
that chicken vimentin accumulated and formed filaments
during differentiation of MELCV-5 cells, whereas endoge-
nous mouse vimentin was lost (data not shown).
Expression of hamster vimentin genes in differentiating
MEL cells. The data presented thus far indicate that MEL
cell lines transfected with chicken vimentin genes accumu-
late either increasing or constant amounts of both the
:,2 - t chicken mRNA and protein during DMSO-mediated differ-
.--_ _ -; . entiation. However, we could not rule out the possibility that
the induction (or lack of repression) of chicken vimentin
mRNA was due to aberrations of DNA transfection. We
therefore transfected MEL cells with a cloned hamster
vimentin gene. The plasmid construct used for this purpose,
pAHV3, is analogous to pAV21, the chicken vimentin plas-
mid. In pAHV3 we substituted the chicken genomic se-
quences and -400 base pairs of hamster APRT gene 5'-
_- so. flanking sequences with a 14.5-kb genomic DNA fragment
im
- containing the entire hamster vimentin gene (73) (Fig. 1).
The hamster vimentin gene lies in the same orientation
relative to vector and APRT gene sequences as the chicken
gene does in pAV21 and is surrounded by -3-kb 5'- and
3'-flanking sequences. pAHV3 DNA was linearized with
Asp718 and introduced into Faprt-585-S cells by calcium
phosphate transfection. Seven independent cell lines con-
taining intact hamster vimentin gene sequences were ob-
tained and used for subsequent analysis. To assay hamster
vimentin RNA levels, we performed quantitative primer
a b
k-r ~0
-u
FIG. 4. Analysis of chicken vimentin RNA 3' termini. Utilization
of chicken vimentin RNA 3' termini was determined by protection
of the 32P-labeled RNA probe shown in panel b. The positions of the
consensus polyadenylation signals (5'-AATAAA-3') are indicated
(95a). The sites are numbered 1 through 4, in a 5'-to-3' direction.
The expected sites of 3' termini, together with the predicted sizes of
protected probe fragments (170, 410, and 430 nt) are shown. (a)
Protected probe fragments resolved on a denaturing polyacrylamide
gel. Lanes: M, pBR322-HpaIl markers; tRNA and FaprtV585-S,
negative controls showing probe protection after hybridization with
10 ,ug of tRNA or Faprt-585-S (uninduced) RNA; 3, protection by
2 p.g of 15-day-old chicken embryo erythroid cell total cytoplasmic
RNA; 4 to 7, protection with 10 jig of MELCV-26 and MELCV-29
RNA from uninduced cells (-) or cells induced with 1.8% DMSO for
4 days (+); 8 and 9, protection by 10 ,ug of total RNA and 1 ,ug of
poly(A)+ RNA, respectively, from MELCV-26 cells cultured in
1.8% DMSO for 3 days; 10 and 11, protection patterns with 1 ,ug of
15-day-old chieken embryo erythroid cell cytoplasmic poly(A)+
RNA and 1 ,ug of 1-week-old chick spinal (sp.) cord poly(A)+ RNA,
respectively. Lanes 1 to 7 were exposed for 48 h, and lanes 8 to 11
were exposed for 7 h. CRBC, Chicken erythrocytes.
6h is due to the presence of chicken vimentin filaments.
Hence, differentiating MELCV-26 cells accumulate filamen-
tous chicken vimentin during differentiation while simulta-
neously losing mouse vimentin. The results of Fig. 5 and 6
were also confirmed in another cell line, MELCV-5; by both
immunoblot and immunofluorescence analysis, we found
c
4
e
a
f
COOMASSIE COOMASSIE
FIG. 5. Analysis of newly assembled vimentin by two-
dimensional gel electrophoresis. MEL cells were grown in the
absence or presence of 1.8% DMSO for 4 days, labeled for 1 h with
[35S]methionine, and fractionated with Triton X-100. Equivalent
amounts of protein-incorporated radioactivity from insoluble resi-
dues were electrophoresed and fluorographed (panels a to d).
Panels: a, Uninduced parental Faprt-585-S MEL cells; b, induced
Faprtt585-S cells; c, uninduced MELCV-26 cells; d, induced
MELCV-26 cells (migrations of mouse [m] and chicken [c] vimentin
are indicated); e and f, portions of Coomassie blue-stained gels
whose fluorographs are shown in panels c and d, respectively. IEF,
Isoelectric focusing; SDS-PAGE, SDS-polyacrylamide gel
electrophoresis.
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FIG. 6. Vimentin-specific immunofluorescence microscopy. MEL cells were cultured in the absence (panels a, b, e, and f) or presence
(panels c, d, g, and h) of 1.8% DMSO for 4 days and prepared for immunofluorescence microscopy with a vimentin-specific antibody. Cells
were visualized with phase-contrast (panels a, c, e, g) and epifluorescence (panels b, d, f, h) optics. Bar, 10 p.m.
extension analysis, using a 32P-labeled oligonucleotide com-
plementary to hamster vimentin mRNA 37 to 56 nt down-
stream from the predicted cap site (73). Figure 7, lane 1,
shows the expected 53- to 57-nt primer extension product
with BHK-21 RNA as a source of hamster vimentin tran-
script (31, 88). Primer extension with Faprt-585-S RNA as
a template was negative (Fig. 7, lanes 2 and 3). Three cell
lines, MELAHV-6, MELAHV-9, and MELAHV-12, ex-
pressed the hamster vimentin RNA at detectable levels,
and all three showed significantly reduced levels of this RNA
upon differentiation (lanes 4 to 9). Undifferentiated
MELAHV-9 and MELAHV-12 cells accumulated hamster
vimentin RNA at -5% of the levels found in BHK-21 cells.
Upon differentiation, hamster vimentin RNA levels fell
2.5-fold in MELAHV-9 cells and 10-fold in MELAHV-12
cells (Table 2). The decrease in hamster vimentin RNA in
MELAHV-6 cells was difficult to measure, as the levels in
undifferentiated cells were low and declined below our limits
of detection in differentiated cells; we estimate the decrease
to be at least fivefold. Quantitation of APRT, -y-actin, and
,-globin RNA levels confirmed that the decline in hamster
vimentin RNA was specific and induction of P-globin RNA
was extensive (Table 2).
Determination of vimentin gene transcription rates by in
vitro nuclear run-on transcription analysis. Our observation
that chicken vimentin RNA increased and murine or hamster
vimentin RNA decreased during MEL cell differentiation
suggests that the differences are due to cis-acting sequences.
To establish the contribution of RNA transcription rates
toward vimentin RNA accumulation levels, we performed in
vitro nuclear run-on transcription analysis (37, 57). Nuclei
were isolated from MEL cells cultured in the absence or
presence of DMSO for 4 days and incubated with [a-
32PJUTP. 32P-labeled RNA was isolated, and transcription
rates were determined by hybridization with excess filter-
bound DNAs. To determine the utility of this technique for
our system, we performed run-on transcriptions using nuclei
isolated from a MEL cell line (MEL-FI) whose endogenous
vimentin, P-globin, and actin RNA accumulation kinetics
had been determined previously (69). In this cell line,
steady-state vimentin RNA falls to 30% of control levels at
24 h, 10% at 48 h, and 4% at 96 h of DMSO-induced
differentiation; actin mRNA levels remain constant through
96 h of differentiation, whereas ,-globin mRNA increases 3-
to 5-fold at 48 h and 10- to 20-fold at 96 h (69). Figure 8a and
Table 3 show the results of nuclear run-on transcriptions in
nuclei obtained from MEL-Fl cells grown in control medium
or in the presence of DMSO for 24, 48, and 96 h. P-Globin
transcription increased to a maximum of 12-fold over control
levels at 96 h, and actin transcription remained fairly con-
stant, falling to only 74% after 96 h of differentiation.
Surprisingly, murine vimentin gene transcription at 24 h of
differentiation decreased only slightly, to 56% of control
levels, and transcription of this gene was maintained at
-40% through 96 h of differentiation. Similar results were
obtained with Faprt-585-S cells; in two independent exper-
iments, murine vimentin transcription decreased to only 40%
of control levels at 96 h of DMSO-induced differentiation
(Fig. 8b; Table 4). Blot analysis of cytoplasmic RNAs from
the same cell preparations used in these experiments con-
firmed the extensive decline (10- to 20-fold) in vimentin
mRNA steady-state levels in both MEL-Fl and Faprt-585-S
cells at 96 h of differentiation (data not shown). Induction of
3-globin gene transcription was only 3.5- to 5-fold in Faprt-
585-S cells; this was due to the high level of P-minor-globin
expression in the undifferentiated state (Fig. 3a, lanes 3 and
4).
In two independent experiments with MELCV-26 nuclei,
C
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FIG. 7. Quantitative primer extension analysis of hamster
vimentin RNA. Extension products generated from a hamster
vimentin-specific 32P-labeled oligonucleotide primer with 5 ,ug of
total cellular RNA templates were resolved on an 8% polyacryl-
amide-8 M urea gel. One-half of each sample was loaded on the gel.
The positions of 54- to 57-nt products, corresponding to correctly
initiated hamster vimentin mRNA, are indicated. Lanes: M,
pBR322-HpaII markers; 1, BHK-21 RNA; 2 to 9, MEL cell line
RNAs from cells grown in the absence (-) or presence (+) ofDMSO
for 4 days. Lane 1 was exposed for 1 day; lanes 2 to 9 were exposed
for 7 days.
transcription of the introduced chicken vimentin gene in-
creased 2.5- to 4-fold (Fig. 8c; Table 4), roughly paralleling
the steady-state RNA levels (Table 1). APRT and ,-globin
gene transcription both increased about two- to threefold,
approximating the increases in the respective steady-state
amounts (Table 1). Transcription of the mouse vimentin gene
in differentiated MELCV-26 cells apparently decreased to
only -70 to 90% of control levels. This value is an overes-
timate, however, as the combination of high levels of
chicken vimentin gene transcription and limited (<10 to
15%) but variable cross-hybridization with the mammalian
DNA sequences obscured the relatively lower mouse-
specific signal. On the basis of these in vitro transcription
experiments, we conclude that the induction of chicken
vimentin RNA in transfected MEL cells is due primarily to
r-DM0.ODrt
-DMSO
*DM3,rO p f.
-DMASO
FIG. 8. In vitro nuclear run-on transcription analysis. Plasmid
DNA dots immobilized to nitrocellulose were hybridized to 32p-
labeled RNA synthesized in isolated MEL cell nuclei, washed, and
exposed to X-ray film. Dots: Vm, detection of endogenous mouse
vimentin gene transcription with pSThvim, a hamster vimentin
DNA plasmid (a strong signal was readily obtained because of the
high sequence homology among mammalian vimentin sequences
[28]); 3, 3-globin; Ac, actin; Vc, chicken vimentin; aprt, hamster
APRT; (-), pT7SP6 vector DNA. Panels: a, transcription in isolated
nuclei from MEL-Fl cells cultured in the absence or presence of
1.8% DMSO, as indicated; b and c, transcription in nuclei from
parental Faprt-585-S cells or MELCV-26 cells (respectively) grown
in the absence or presence of DMSO for 4 days. The data in panels
b and c are from experiment 2 (see the text).
an increase in transcription, in contrast to a lesser change in
the transcription of the endogenous vimentin gene relative to
murine vimentin RNA levels. Actin transcription rates in-
creased two- to threefold in Faprt-585-S and MELCV-26
cells; in separate experiments, the former accumulated ap-
proximately twofold more actin RNA during differentiation,
and the latter maintained actin RNA at constant levels
(Table 1). Since the determinations of actin transcription
were only performed once and steady-state actin mRNA was
not measured within the same experiment, the observed
disparity in MELCV-26 actin gene transcription and RNA
accumulation may not be significant.
TABLE 2. Quantitation of steady-state RNA levels in undifferentiated and differentiated MELAHV cells
Steady-state RNA ratio (differentiated level/undifferentiated level) of:
Cell line Approximate no. ofCell1 netransfected genes/cella Hamster Hamster Mouse MouseMos atn
vimentin APRTb ,B-major-globinb n-minor globinb Mouse y-actinb
MELAHV-6 2-4 <0.2c 0.6 48 4.0 0.6
MELAHV-9 1-2 0.4b 1.0 11 2.7 1.4
MELAHV-12 46 0.1b 0.7 17 3.8 1.5
a Estimated from genomic DNA blots (data not shown).
b Determined by Cerenkov radiation in excised gel slices (gels not shown for 1-globin, APRT, and actin determinations).
c See the text.
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TABLE 3. Transcription in nuclei isolated from MEL-Fl cells
Mouse vimentin 3-Globin Actin
Treatment Fraction a Fraction a Fraction
CpMa of control cpm of control CpMa of control
No DMSO (control) 83 (1.0) 20 (1.0) 142 (1.0)
DMSO (24 h) 47 0.56 42 2.1 114 0.80
DMSO (48 h) 32 0.39 116 5.8 110 0.78
DMSO (96 h) 35 0.42 242 12 104 0.74
a Net Cerenkov radiation, with background hybridization to pT7SP6 filter dots (18 to 20 cpm) subtracted.
DISCUSSION In the second mechanism, divergent cis-acting vimentin
regulatory elements are responsible for activation (or
Divergence of vimentin expression in avian and mammalian derepression) in avian erythropoiesis and repression (or
erythropoiesis is manifested in the expression of transfected deactivation) in mammalian erythropoiesis. The observed
vimentin genes in differentiating MEL cells. Differentiation of differences in gene expression therefore would be attribut-
MEL cells in vitro has long served as a model system for able to changes in the target vimentin sequence itself. This
mammalian erythropoiesis (30; reviewed in reference 55). mechanism predicts that a transfected chicken vimentin gene
Studies of exogenous globin genes introduced into MEL would not be regulated in a manner appropriate for the
cells have delineated the cis-acting regulatory regions re- differentiating host murine erythropoietic cell. Furthermore,
sponsible for the induction of globin genes during erythro- if positively acting factors that activate the vimentin gene in
poiesis (14, 16, 17, 93, 94). In the present study, we under- chicken erythroid cells have been conserved in mammals as
took MEL cell transfection experiments as an approach to part of the general erythropoietic program (as we would
understanding the molecular basis for divergent vimentin expect them to be if they regulate the expression of a number
gene regulation in avian and mammalian erythropoiesis. of genes), then we would predict transfected chicken
Two simple alternative mechanisms can explain the ob- vimentin genes to be activated or derepressed in differenti-
served differences in vimentin regulation in avian and mam- ating MEL cells.
malian erythropoiesis. For both mechanisms, we presume Our results are consistent with the second mechanism
that expression of vimentin genes is regulated by interac- described above. Chicken vimentin RNA levels either in-
tions of trans-acting regulatory factors with cis-linked se- creased significantly (2- to 10-fold) or remained constant in
quences. In the first mechanism, a divergence in trans-acting the majority of the chicken vimentin-expressing MEL cell
regulatory factors is responsible for the differences in lines undergoing DMSO-mediated differentiation. The in-
expression. In avian erythroid cells, the vimentin gene is crease in chicken vimentin RNA and the decline in mamma-
either activated or derepressed by a trans-acting factor lian vimentin RNA in differentiating MEL cells suggest that
during terminal differentiation. In mammals, however, this the two sequences respond to different regulatory' signals
activating factor either is absent or has been replaced or and that this differential response is mediated by a difference
overridden by the activity of another factor, resulting in the in cis-acting regulatory sequences. The increased transcrip-
repression of vimentin RNA levels during erythropoiesis. If tion of the chicken vimentin gene in these differentiating
vimentin cis-acting regulatory sequences have been con- cells further suggests a conservation of positively acting
served, we predict that transfected chicken vimentin genes factors that are capable of interacting with similarly con-
would be negatively regulated in differentiating MEL cells. served chicken vimentin regulatory elements. It appears that
TABLE 4. Transcription in nuclei isolated from Faprt-585-S and MELCV-26 cells
Transcription level(s) in:
Expt 1 Expt 2
Cells
cpma cpma Differentiated/ cpma cpma Differentiated/
Undifferentiated Differentiatedb undifferentiated Undifferentiated Differentiatedb undifferentiated
cell cell cell ratio cell cell cell ratio
Faprt-585-S
Mouse vimentin 27 11 0.41 30 14 0.46
,3-Globin 6 30 5.0 14 49 3.5
Actin NDC ND ND 22 51 2.3
MELCV-26
Chicken vimentin 28 120 4.2 182; 176d 430; 468d 2.5e
j-Globin 7 21 3.1 18; 16d 46; 46d 2.7e
Hamster APRT 10 30 2.9 30 58 1.9
Actin ND ND ND 9 35 3.9
Mouse vimentin 33 24 0.72f 50 44 0.87f
a Net Cerenkov radiation with background hybridization to pT7SP6 filter dots (18 to 20 cpm) subtracted.
I Nuclei from cells cultured in DMSO for % h.
c ND, Not determined.
d Radioactivity in duplicate filters from duplicate hybridizations.
eThese ratios reflect the averages of the duplicate determinations.
f The ratios given here for mouse vimentin transcription were overestimated because of cross-hybridization with chicken vimentin transcripts (see the text).
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transfected chicken vimentin sequences respond to these
putative factors in a manner appropriate for chicken
vimentin sequences in an erythropoietic environment. A
similar situation, in which an apparent divergence of target
gene sequences is juxtaposed with a functional conservation
of trans-acting regulatory factors, has been described for the
avian and mammalian lens crystallins (43, 44, 72). Although
mammalian genomes contain no b-crystallin genes, chicken
B-crystallin genes are appropriately regulated in a lens-
specific fashion when microinjected directly into murine cell
nuclei (44) or expressed in transgenic mice (43). Hence, both
chicken B-crystallin and vimentin genes are appropriately
expressed in murine xenogeneic environments according to
the specificity of the species from which the genes origi-
nated.
The divergence of vimentin gene expression in avian and
mammalian erythropoiesis, as mediated by cis-acting se-
quences, contrasts with the mechanism of fetal recruitment
of embryonic globin genes in simian primates (12, 42). In
simian primates, modern -y-globin genes exhibit a fetal pat-
tern of expression but are believed to have evolved from an
ancestral proto-y gene which exhibited an embryonic pattern
of expression (25). In most nonprimate mammals, the de-
scendants of this proto--y gene have maintained an embry-
onic pattern of expression. By studying the behavior of
cloned human y-globin genes during embryogenesis of
transgenic mice, Chada et al. (12) and Kollias et al. (42) have
observed an embryonic, rather than a fetal, pattern of
-y-globin gene expression. The results suggest that the fetal
recruitment of embryonic globin genes in simian primates is
due to a temporal change in the expression of trans-acting
factors specific for y-like globin genes rather than a diver-
gence of cis-acting ly-globin regulatory elements (12, 42).
Moreover, these results suggest that the trans-acting factors
governing y-like globin gene expression, as well as the
sequences with which they interact, have been conserved
from rodents to humans (12, 42).
It is formally possible that increased accumulation of
chicken vimentin RNA in differentiating MEL cells is a
manifestation of gene transfection. Exogenous vimentin
genes may be released from appropriate regulation by virtue
of their aberrant chromosomal locations (assumed to be
random), the exclusion of regulatory sequences in the plas-
mid DNA constructs used for transfection, or the proximity
of vector sequences. For example, transfected cloned a-
globin genes are expressed at inappropriately high levels in
nonerythroid cells (38, 59, 87) and also appear to be maxi-
mally expressed in both undifferentiated and differentiated
MEL cells (17). In contrast, a-globin genes introduced into
MEL cells by chromosome-mediated transfer are appropri-
ately regulated during differentiation (17, 19-21), suggesting
that chromatin configuration and/or local chromosome posi-
tion effects factors play a key role in the regulated expres-
sion of a-globin gene expression. Several lines of evidence
argue against these possibilities for transfected vimentin
gene expression. First, transfected hamster vimentin genes
were found to be appropriately regulated. Of three MEL cell
lines expressing hamster vimentin genes, all exhibited sig-
nificantly reduced levels of hamster vimentin RNA after
DMSO-mediated differentiation. It is therefore unlikely that
the observed patterns of chicken vimentin expression in
differentiating MEL cells are due to the absence of regula-
tory influences particular to the murine vimentin chromo-
somal locus. Second, we also obtained one MEL cell line
containing vimentin sequences transferred on a genomic A
recombinant, XV8 (10), which contains the entire chicken
vimentin gene plus 6-kb 5'-flanking and 5-kb 3'-flanking
sequences. This cell line expressed an increased amount of
chicken vimentin RNA subsequent to DMSO-induced differ-
entiation, albeit at low levels (data not shown). We therefore
believe that both vimentin plasmid constructs used in this
study contain sufficient flanking sequences to confer appro-
priately regulated expression and that the differences ob-
served are not due to artificial exclusion of regulatory
elements or interference by cis-linked vector or APRT gene
sequences. Rather, the increased accumulation of chicken
vimentin RNA and decreased accumulation of hamster
vimentin RNA in differentiating MEL cells accurately reflect
the phylogenetic class-specific differences of the transfected
gene sequences. Finally, our results from in vitro nuclear
run-on transcription experiments suggest that the differences
in murine and chicken vimentin RNA accumulation in dif-
ferentiating MEL cells are mediated in part by posttranscrip-
tional mechanisms (see below for further discussion) which
are independent of the above-mentioned transcriptional ef-
fects.
Nondiscriminatory utilization of chicken vimentin polyade-
nylation signals in MEL cells. The tissue-specific and devel-
opmentally regulated utilization of chicken vimentin RNA 3'
termini suggests an important, albeit unknown, biological
role for the differential expression of vimentin 3' noncoding
sequences (10). We therefore examined the patterns of
chicken vimentin transcript polyadenylation in transfected
MEL cell lines to detemine whether the mechanisms respon-
sible for the differential utilization of vimentin polyadenyla-
tion sites in chicken definitive erythroid cells have been
conserved in mammalian erythropoietic cells. The data of
Fig. 4 demonstrate that the chicken vimentin 3' termini are
not utilized in a pattern distinctive of chicken definitive
erythroid cells. It is possible that our DNA construct used
for transfections lacked sufficient DNA sequence informa-
tion to confer erythroid cell-specific transcript cleavage and
polyadenylation. However, all three chicken vimentin 3'
termini were generated at the appropriate sites, indicating
that sufficient downstream sequences indeed were present to
direct proper transcript cleavage and polyadenylation (re-
viewed in reference 4). Our data suggest that, although the
factors responsible for chicken vimentin gene activation
have been functionally conserved in avian and mammalian
erythropoiesis, the mechanism by which the chicken
erythroid cell-specific pattern of polyadenylation site utiliza-
tion occurs has diverged.
The role of transcriptional and posttranscriptional mecha-
nisms in the regulation of vimentin mRNA levels in differen-
tiating MEL cells. We performed in vitro nuclear run-on
transcription experiments to determine the contribution of
altered vimentin gene transcription rates to the changes in
both endogenous and transfected vimentin mRNA steady-
state levels. In two untransfected MEL cell lines, we found
that transcription of the mouse vimentin gene reproducibly
decreased to -40% of control levels after 96 h of DMSO-
mediated differentiation. This -2-fold reduction in vimentin
transcription in vitro contrasts with a corresponding 25-fold
decrease in steady-state vimentin mRNA (69; this paper).
The apparent quantitative disparity in changes of vimentin
transcription rates and steady-state vimentin mRNA levels
suggests that the decline in murine vimentin mRNA in
differentiating MEL cells is due in part to posttranscriptional
mechanisms. However, vimentin gene transcription in iso-
lated nuclei may not accurately reflect the quantitative
changes in transcription in vivo. Although it is widely
assumed that reinitiation does not occur in these transcrip-
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tion reactions (e.g., see reference 37), an overestimate of
vimentin gene transcription during MEL cell differentiation
could have been obtained. For example, the repression
might be mediated by the induction of a labile or diffusible
transcription factor whose activity is lost during the purifi-
cation of nuclei. It should be noted, however, that the
disparity in the rate of transcriptional decrease in vitro (56%
of control levels at 24 h, -40% at 48 h, and -40% at 96 h)
and the rate of steady-state mRNA level decrease (30% of
control levels at 24 h, 10% at 48 h, and 4% at 96 h) argues
against such a possibility. Nevertheless, direct in vivo mea-
surements of vimentin gene transcription rates and RNA
decay kinetics will be necessary to quantitate the absolute
contributions of transcriptional and posttranscriptional reg-
ulation to the decline in steady-state vimentin mRNA levels
in differentiating MEL cells. Indeed, a combination of
changes in transcription rate and posttranscriptional RNA
processing, resulting in an overall greater change in mRNA
steady-state levels, has been demonstrated for the cell cycle
regulation of cellular thymidine kinase (49, 61, 85) and
histone (81) mRNAs, as well as for the induction of hormon-
ally responsive RNAs (9, 71, 78). Transcriptional (27, 79) and
posttranscriptional (50) mechanisms also mediate the cell cycle
regulation of dihydrofolate reductase mRNA levels.
A comparison of chicken and mouse vimentin gene tran-
scription rates with the corresponding steady-state mRNA
levels in differentiating MEL cells suggests that the diver-
gent expression of these two genes in avian and mammalian
erythropoiesis is effected at both the transcriptional and
posttranscriptional levels. The increase in chicken vimentin
RNA levels during differentiation of one transfected cell line,
MELCV-26, apparently is due to an increase in the rate of
transcription as the increase in steady-state chicken RNA
levels approximated the increase in transcription. The data
suggest that mammalian vimentin cis-acting sequences have
diverged from chicken sequences in such a way as to
respond to both transcriptional repression (or deactivation)
and differentiation-induced RNA destabilization.
Expression and persistence of filamentous chicken vimentin
in differentiating MEL cells. Our studies show that differen-
tiating MEL cells expressing chicken vimentin RNA accu-
mulate vimentin filaments in the absence of endogenious
mouse vimentin expression. Inappropriate expression of
stable intermediate filaments in cultured cells by DNA
transfection or microinjection of mRNA has been reported
for the keratins and for desmin (32, 46, 74). Together, these
results suggest that intermediate filament proteins can poly-
merize in vivo in the absence of accessory proteins; how-
ever, the presence of heterologous intermediate filament-
associated proteins has not been ruled out in any of these
cases.
We presume that chicken and mouse vimentins copoly-
merize when they are coexpressed in undifferentiated cells;
although our antibodies react with both chicken and mouse
vimentin and hence are not capable of discriminating be-
tween the two molecules by immunofluorescence micros-
copy, copolymerization of vimentin and desmin, vimentin
and glial fibrillary acidic protein, and vimentin and neurofila-
ment protein has been described (35, 75, 76, 82, 83). As
chicken vimentin-expressing MEL cells differentiate, the
composition of intermediate filaments probably changes
gradually frotn a mouse-chicken vimentin heteropolymer to
a chicken vimentin homopolymer. Accumulation of chicken
vimentin filaments in differentiating MEL cells argues
against the possibility that endogenous murine vimentin
filaments are normally removed from the cytoplasm by
accelerated protein turnover, for example, by activation of a
Ca2+-dependent vimentin-specific protease (66, 67) in re-
sponse to an influx of Ca2+ ions (15, 48). The functionally
conserved specificity of the vimentin-desmin-specific Ca2 -
activated protease from fish to humans (68) suggests that if
such an activity were activated in differentiating MEL cells,
chicken vimentin also would be degraded. Since a MEL cell
line that expresses low levels of chicken vimentin during
differentiation also accumulates filaments in the absence of
endogenous murine vimentin (data not shown), we believe
that the accumulation of filaments is not due to an excess of
protease substrate. Our results support a previous conten-
tion that the accumulation of vimentin filaments is deter-
mined primarily by the levels of newly synthesized vimentin
(5, 62), which in turn are regulated at the level of mRNA
abundance (10, 69).
Experimentally induced expression of vimentin filaments
in MEL cells had no obvious effects on MEL cell differentia-
tion. In the MEL cell lines described here, 3-globin mRNA
levels accumulated normally and cells exhibited patterns of
growth kinetics and reductions in cell volume typical of
MEL cell differentiation (data not shown; 55). We have
speculated previously that removal of vimentin filaments in
mammalian erythropoiesis facilitates the enucleation proc-
ess (69). The experiments described here do not address this
issue, since enucleation occurs subsequent to the period of
MEL cell differentiation studied and, furthermore, mainte-
nance of differentiating MEL cells to the anucleate
reticulocytic stage is inherently problematical (90).
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